Login / Signup

Fatigue and health-related quality of life in paroxysmal nocturnal haemoglobinuria: a post-hoc analysis of the pegcetacoplan PEGASUS trial data.

Jens Peter PanseKoo WilsonJesse FishmanPiotr WojciechowskiMarlena WdowiakRegina HorneffChristopher J PatriquinMonika OliverZalmai Hakimi
Published in: European journal of haematology (2023)
Compared with eculizumab, pegcetacoplan was associated with clinically meaningful greater improvements on a majority of FACIT-fatigue items. This article is protected by copyright. All rights reserved.
Keyphrases